Search Result

Search Results for " mpo "

Targets

Others

475

Compounds

Natural Products

Recombinant Proteins

115

Libraries

Cat No.	Product Name	Synonyms	Targets
T19972	MPO	5-(4'-Methoxyphenyl)-oxazole	Others
	MPO (5-(4'-Methoxyphenyl)-oxazole) is a hatch and growth of Caenorhabditis Elegans inhibitor.		Others
T5340	MPO-IN-28		Glutathione Peroxidase
	MPO-IN-28 is a novel potent, irreversible Myeloperoxidase (MPO) inhibitor with IC50 of 44 nM.		Glutathione Peroxidase
T23745	APA-APA-MPO	APA APA MPO,APAAPAMPO
	APA-APA-MPO is a PCAF bromodomain/Tat-AcK50 association inhibitor.
T38914	MPO-IN-3
	MPO-IN-3, a powerful inhibitor of myeloperoxidase (MPO), is described as such in example 191 of WO2013068875A1. MPO, a heme-containing enzyme, is classified under the peroxidase superfamily.
T40137	MPO-IN-1
	MPO-IN-1 is a powerful and orally bioavailable indole-containing inhibitor that acts irrevocably on myeloperoxidase (MPO). With IC50 values of 2.6 μM and 5.3 μM for MPO and thyroid peroxidase (TPO), respectively, MPO-IN-...
T23746	APA-H-MPO	APAHMPO
	APA-H-MPO is a PCAF bromodomain/Tat-AcK50 association inhibitor.
T60281	MPO-IN-4
	MPO-IN-4 (compound 12) is a potent and selective myeloperoxidase (MPO) inhibitor with an IC 50 of 25 nM. MPO-IN-4 also demonstrates inhibition of thyroid peroxidase (TPO) with IC50 of 2.2 μM. MPO-IN-4 has no effect on me...
T62347	MPO-IN-5
	MPO-IN-5 is a potent, irreversible inhibitor of MPO (myeloperoxidase). MPO-IN-5 inhibits MPO peroxidation (IC50: 0.22 μM) and hERG binding (IC50: 2.8 μM). 23000 M 1s 1.
T13491	Neuromuscular-targeting compound 1		Others
	Neuromuscular-targeting compound 1 can be used to study muscular dystrophy and neuromuscular-related diseases.		Others
T11427	Antibacterial compound 2		Antifungal
	Antibacterial compound 2 is a potent antimicrobial agent effective against many human veterinary pathogens, inhibiting multi-drug resistant staphylococci, enterococci and streptococci, as well as anaerobic bacteria.		Antifungal
T3445	Importazole		Apoptosis , Others
	Importazole is an inhibitor of the nuclear transport receptor importin-β.		Apoptosis , Others
T36506	Tempone	4-Oxo-tempo
	Tempone is an aminooxyalkane that acts as a free radical scavenger and reacts with reactive oxygen species (ROS). Intravenous Tempone reduces mean arterial pressure in spontaneously hypertensive rats.
T131725	Compound TCFN92660
	Compound TCFN92660 is a useful organic compound for research related to life sciences. The catalog number is T131725 and the CAS number is 56070-89-4.
T10337	Antimicrobial Compound 1		Antibacterial
	Antimicrobial Compound 1 is an alkyl pyridinium compound with Tail 12C, Head 4-carboxyl. Antimicrobial Compound 1 exhibits antimicrobial activities against B. subtilis and E. coli.		Antibacterial
T0535	Memantine Related Compound B	3,5-Dimethyl-1-adamantanol	Others
	Memantine Related Compound B (3,5-Dimethyl-1-adamantanol) is an impurity of Memantine.		Others
T9544	Compound 1T-0216		Others
	Compound 1T-0216 is a blocker of AKT1-FAK interactions and reduces stimulation of FAK phosphorylation by extracellular stress in human SW620 colon cancer cells without affecting basal FAK phosphorylation.		Others
TPL0053	Compound 227105-11-5
	Compound 227105-11-5 is a useful organic compound for research related to life sciences. The catalog number is TPL0053 and the CAS number is 227105-11-5.
T50125	Compound C749
	Compound C749 is a useful organic compound for research related to life sciences. The catalog number is T50125 and the CAS number is 57-03-4.
T7944	VPS34 inhibitor 1 (Compound 19, PIK-III analogue)	PIK-III analogue	PI3K
	VPS34 inhibitor 1 (Compound 19, PIK-III analogue) (PIK-III analogue) is a potent and selective inhibitor of VPS34( IC50 : 15 nM)		PI3K
T5363	Tempo	2,2,6,6-Tetramethylpiperidinooxy	Free radical scavengers , Reactive Oxygen Species , DNA/RNA Synthesis , Mitochondrial Metabolism
	Tempo (2,2,6,6-Tetramethylpiperidinooxy) has a wide range of applications including use as a free radical scavenger, a reagent in organic synthesis and as a structural probe in electron spin resonance spectroscopy.
T67752	Compound V007-6018		Others
	Compound V007-6018 is a pharmaceutical compound used for drug screening.		Others
T9184L	Compound 3344 hydrochloride	4-(2,3-dihydro-1,4-benzodioxin-5-yl)-~{N}-[3-[(dimethylamino)methyl]phenyl]-2-methoxy-aniline hydrochloride(2368246-78-8 free base),Compound 3344 hydrochloride (2368246-78-8 free base)	Ras
	Compound 3344 hydrochloride is an inhibitor of KRAS-effector interactions，with an affnity of 126nm.		Ras
T38387	Compound C108		GTPase
	Compound C108 is an inhibitor of GTPase-activating protein SH3 domain-binding protein 2 (G3BP2). Compound C108 can be used in studies about breast tumors and esophageal squamous cell carcinoma.		GTPase
T60198	Compound STK672155		Others
	Compound STK672155 can be used for research in the fields of chemistry and life sciences.		Others
T3586	Compound 401	2-morpholino-4H-pyrimido[2,1-a]isoquinolin-4-one	DNA-PK
	Compound 401 (2-morpholino-4H-pyrimido[2,1-a]isoquinolin-4-one) is a synthetic DNA-PK inhibitor (IC50 = 0.28 μM) that also targets mTOR but not PI3K.		DNA-PK
T72082	Compound T72082(SC)		ROS
	ROS-IN-1 is a mitochondrial ROS inhibitor that can be used to reduce oxidative stress or inhibit reactive oxygen species (ROS) production.		ROS
T12262L1	NPS ALX Compound 4a hydrochloride(1:1)		5-HT Receptor
	NPS ALX Compound 4a hydrochloride(1:1) is a potent and selective 5-hydroxytryptamine6 (5-HT6) receptor antagonist, with an IC50 of 7.2 nM and a Ki of 0.2 nM.		5-HT Receptor
T77771	Compound 10w		Others
	Compound 10w, a substituted pyrazolo[1,5-a]pyrimidinamide compound, is a ZSTK474 analog that shows anticancer activity against HeLa cells.		Others
T13623	Compound 48/80 trihydrochloride	C48/80 trihydrochloride	Phospholipase
	Compound 48/80 trihydrochloride (C48/80 trihydrochloride) is a mixture of N-methyl-p-methoxyphenethylamine and formaldehyde in a condensation reaction.Compound 48/80 trihydrochloride is a mast cell degranulator and hista...		Phospholipase
T13572	Cancer-Targeting Compound 1		Others
	Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among othe...		Others
T9545	Compound 1T-0219 (SC)		FAK
	Compound 1T-0219 (SC) is a blocker of AKT1-FAK interaction reducing the stimulation of FAK phosphorylation in response to extracellular pressure in human SW620 colon cancer cells without affecting basal FAK phosphorylati...		FAK
T19428	Mito-TEMPO		Reactive Oxygen Species , Mitochondrial Metabolism
	Mito-TEMPO is a mitochondria-targeted superoxide dismutase mimetic. Mito-TEMPO scavenges superoxide and alkyl radicals and prevents mitochondrial oxidation, necrosis and apoptosis.		Reactive Oxygen Species , Mitochondrial Metabolism
T6699	Tempol	TMPN,Tanol,4-Hydroxy-TEMPO	Reactive Oxygen Species , ROS , Autophagy
	Tempol (Tanol) is a superoxide scavenger. It has anti-inflammatory, neuroprotective and analgesic effects.		Reactive Oxygen Species , ROS , Autophagy
T22739	DMPO	5,5-Dimethyl-1-pyrroline N-oxide	Others
	DMPO (5,5-Dimethyl-1-pyrroline N-oxide) is a kind of water-soluble nitric oxide spin trap, which allows the measurement of oxygen-centered free radicals in biological systems at room temperature using electron spin reson...		Others
T0547	FlutaMide Related CoMpound B		Others
	FlutaMide Related CoMpound B is used as pharmaceutical intermediates.		Others
T67774	Compound CDy9		Carbonic Anhydrase
	Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.		Carbonic Anhydrase
T9853	STING activator Compound 53		STING
	STING activator Compound 53 based on an oxindole core structure demonstrated robust on-target functional activation of STING (human EC50 185 nM) in immortalised and primary cells and a cytokine induction fingerprint cons...		STING
T35398	MINA53 inhibitor (Compound 10)		Others
	MINA53 inhibitor (Compound 10) is an inhibitor of MINA53.		Others
T67779	Compound TPX-0046		c-RET
	Compound TPX-0046 is an inhibitor of RET. Compound TPX-0046 can inhibit the RET autophosphorylation. Compound TPX-0046 can be used for the research of cancer.		c-RET
T131230	Compound N051-0059
	Compound N051-0059 is a useful organic compound for research related to life sciences and the catalog number is T131230.
T131184	Compound N069-0074
	Compound N069-0074 is a useful organic compound for research related to life sciences and the catalog number is T131184.
T131373	Compound N006-0008
	Compound N006-0008 is a useful organic compound for research related to life sciences and the catalog number is T131373.
T131704	Compound 0080-0015
	Compound 0080-0015 is a useful organic compound for research related to life sciences and the catalog number is T131704.
T131713	Compound 0407-0024
	Compound 0407-0024 is a useful organic compound for research related to life sciences and the catalog number is T131713.
T131668	Compound 0449-0077
	Compound 0449-0077 is a useful organic compound for research related to life sciences and the catalog number is T131668.
T131287	Compound N037-0036
	Compound N037-0036 is a useful organic compound for research related to life sciences and the catalog number is T131287.
T131362	Compound N013-0010
	Compound N013-0010 is a useful organic compound for research related to life sciences and the catalog number is T131362.
T131718	Compound N064-0028
	Compound N064-0028 is a useful organic compound for research related to life sciences and the catalog number is T131718.
T131344	Compound N016-0024
	Compound N016-0024 is a useful organic compound for research related to life sciences and the catalog number is T131344.
T131345	Compound N016-0023
	Compound N016-0023 is a useful organic compound for research related to life sciences and the catalog number is T131345.

Compounds

MPO

T19972

Synonym: 5-(4'-Methoxyphenyl)-oxazole

Target: Glutathione Peroxidase

APA-APA-MPO

T23745

Synonym: APA APA MPO,APAAPAMPO

Neuromuscular-targeting compound 1

T13491

Synonym:

Target: Others

Antibacterial compound 2

Target: Apoptosis, Others

Antimicrobial Compound 1

T10337

Synonym:

Target: Antibacterial

Memantine Related Compound B

T0535

Synonym: 3,5-Dimethyl-1-adamantanol

VPS34 inhibitor 1 (Compound 19, PIK-III analogue)

T7944

Synonym: PIK-III analogue

Target: PI3K

Tempo

T5363

Synonym: 2,2,6,6-Tetramethylpiperidinooxy

Target: Free radical scavengers, Reactive Oxygen Species, DNA/RNA Synthesis, Mitochondrial Metabolism

Compound 3344 hydrochloride

T9184L

Synonym: 4-(2,3-dihydro-1,4-benzodioxin-5-yl)-~{N}-[3-[(dimethylamino)methyl]phenyl]-2-methoxy-aniline hydrochloride(2368246-78-8 free base),Compound 3344 hydrochloride (2368246-78-8 free base)

Synonym: 2-morpholino-4H-pyrimido[2,1-a]isoquinolin-4-one

NPS ALX Compound 4a hydrochloride(1:1)

T12262L1

Synonym:

Target: 5-HT Receptor

Compound 48/80 trihydrochloride

T13623

Synonym: C48/80 trihydrochloride

Target: Phospholipase

Cancer-Targeting Compound 1

T13572

Synonym:

Target: Others

Compound 1T-0219 (SC)

Target: Reactive Oxygen Species, Mitochondrial Metabolism

Tempol

T6699

Synonym: TMPN,Tanol,4-Hydroxy-TEMPO

Target: Reactive Oxygen Species, ROS, Autophagy

DMPO

T22739

Synonym: 5,5-Dimethyl-1-pyrroline N-oxide

Target: Others

FlutaMide Related CoMpound B

Target: Carbonic Anhydrase

STING activator Compound 53

T9853

Synonym:

Target: STING

MINA53 inhibitor (Compound 10)

Cat No.	Product Name	Targets
TPL0186	Compound 1769-24-0
	Compound 1769-24-0 is a natural product for research related to life sciences. The catalog number is TPL0186 and the CAS number is 1769-24-0.
TN1582	Compound TN1582(SC)	Antiviral
	Dihydromollugin is a naphthol ester found in Rubia cordifolia that may have anti-tumour, virus-inhibiting and other activities.	Antiviral
TC0036	Compound Lup-20(29)-en-3-yl acetate	IL Receptor , VEGFR , Others , TNF , COX
	Lupeol acetate, a derivative of Lupeol, inhibits the progression of rheumatoid arthritis by downregulating TNF-α, IL-1β, MCP-1, COX-2, VEGF and granzyme B.	IL Receptor , VEGFR , Others , TNF , COX
TN6408	New compound 6
	New compound 6 is a natural product of Schisandra, Schisandraceae. The catalog number is TN6408. New compound 6 can be used as a reference standard.
TN6407	New compound 5
	New compound 5 is a natural product of Schisandra, Schisandraceae. The catalog number is TN6407. New compound 5 can be used as a reference standard.
TN6410	New compound 3
	New compound 3 can be used for related research in the field of life sciences, and its product number is TN6410.
TN6434	New compound 4
	New compound 4 is a natural product of Pueraria, Fabaceae. The catalog number is TN6434. New compound 4 can be used as a reference standard.
T19204	Compound 2	Others
	Compound 2 is used for the research of metabolic bone diseases.	Others
TN6550	New compound 2
	New compound 2 is available for research in the life sciences and is product number TN6550.
T82738	Chisocheton compound F
	Chisocheton compound F, a natural product, can be isolated from the stem bark of Melia toosendan [1].
T75618	Sorbifolin
	Sorbifolin, a flavone glucoside isolated from Pterogyne nitens, exhibits myeloperoxidase (MPO) inhibitory and radical scavenging activities. This compound functions as an effective MPO inhibitor, demonstrated by its IC 5...

Natural Products

Compound Lup-20(29)-en-3-yl acetate

TC0036

Synonym:

Target: IL Receptor, VEGFR, Others, TNF, COX

Chisocheton compound F

Recombinant Proteins

Species：

Expression System：

Tag：

Cat No.	Product Name	Species	Expression System
TMPJ-00833	MPO Protein, Mouse, Recombinant (His)	Mouse	HEK293 Cells
	Myeloperoxidase (MPO) is a hemecontaining enzyme belonging to the XPO subfamily of peroxidases. It is an abundant neutrophil and monocyte glycoprotein that catalyzes the hydrogen peroxidedependent conversion of chloride,...
TMPY-05252	Myeloperoxidase/MPO Protein, Human, Recombinant (His)	Human	HEK293 Cells
	MPO (myeloperoxidase) is a peroxidase enzyme secreted by activated leukocytes that plays a pathogenic role in cardiovascular disease, mainly by initiating endothelial dysfunction. Myeloperoxidase (MPO) is an important en...
TMPY-01041	Compound TMPY-01041

TMPY-05325	Exosome Component 9/EXOSC9 Protein, Human, Recombinant (His)	Human	Baculovirus Insect Cells
	Exosome Component 9/EXOSC9 Protein, Human, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 51.3 kDa and the accession number is Q06265-1.
TMPJ-00960	TMPO Protein, Human, Recombinant (His)	Human	E. coli
	Thymopentin is a member of the LEM family. Thymopentin is expressed in many tissues, highly in the adult thymus and fetal liver. The N-terminal contains two structurally independent domains, LEM domain and LEM-like domai...
TMPY-00359	C1s-A subcomponent Protein, Mouse, Recombinant (His)	Mouse	HEK293 Cells
	C1s-A subcomponent Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 76.6 kDa and the accession number is AAH18319.1.

MPO Protein, Mouse, Recombinant (His)

TMPJ-00833

Species: Mouse

Expression System: HEK293 Cells

Myeloperoxidase/MPO Protein, Human, Recombinant (His)

TMPY-05252

Species: Human

Expression System: HEK293 Cells

Exosome Component 9/EXOSC9 Protein, Human, Recombinant (His)

TMPY-05325

Species: Human

Expression System: Baculovirus Insect Cells

TMPO Protein, Human, Recombinant (His)

TMPJ-00960

Species: Human

Expression System: E. coli

C1s-A subcomponent Protein, Mouse, Recombinant (His)

TMPY-00359

Species: Mouse

Expression System: HEK293 Cells

Cat No.	Product Name
L7000	Bioactive Lipid Compound Library	385 compounds
	A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, ...
L2620	Anti-Neurodegenerative Disease Compound Library	2154 compounds
	A unique collection of 2154 compounds related to neurodegenerative diseases can be used for HTS or HCS；
L1120	AMPK-Targeted Compound Library	80 compounds
	80 well-chosen unique AMPK-targeted small molecules；
L3200	Autophagy Compound Library	1248 compounds
	A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L1110	Microtubule-Targeted Compound Library	142 compounds
	A unique collection of 142 microtubule-targeted compounds can be used in HTS and HCS;
L1310	Cytoskeletal Signaling Pathway Compound Library	759 compounds
	A unique collection of 759 cytoskeleton-related compounds, can be used for HTS and HCS；
L1380	Transcription Factor-Targeted Compound Library	695 compounds
	Well-chosen 695 compounds with unique structures targeting transcription factor;
L2120	Anti-Cancer Clinical Compound Library	2545 compounds
	A unique collection of 2545 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS);
L1710	Anti-COVID-19 Compound Library	1133 compounds
	A unique collection of 1133 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents；
L2160	Anti-Cancer Active Compound Library	3188 compounds
	A unique collection of 3188 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L1800	Anti-Infection Compound Library	2938 compounds
	A unique collection of 2938 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc;
L2130	Anti-Cancer Metabolism Compound Library	1268 compounds
	A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);
L2192	Anti-Pancreatic Cancer Compound Library	2238 compounds
	A unique collection of 2238 pancreatic cancer related compounds can be used in HTS and HCS;
L3700	JAK-STAT Compound Library	252 compounds
	A unique collection of 252 JAK/STAT signaling targeted compounds for high throughput and high content screening;
L3500	Histone Modification Compound Library	469 compounds
	A unique collection of 469 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);
L2700	Adrenergic Receptor-Targeted Compound Library	193 compounds
	A unique collection of 193 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification;
L8710	Cuproptosis Compound Library	400 compounds
	TargetMol’s Cuproptosis Compound Library is a collection of 400 compounds related to copper-dependent death that can be used to study its mechanism and related diseases.
L8700	Ferroptosis Compound Library	779 compounds
	A unique collection of 779 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study；
L9420	Exosome Compound Library	76 compounds
	76 exosome-related compounds that can be used for high-throughput and high-content screening.
L8600	Ubiquitination Compound Library	210 compounds
	A unique collection of 210 ubiquitination related small chemicals can be used for high throughput and high content screening；
L2400	Endocrinology-Hormone Compound Library	784 compounds
	A unique collection of 784 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L5400	Anti-Cardiovascular Disease Compound Library	1408 compounds
	A unique collection of 1408 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);
L5500	Toxic Compound Library	262 compounds
	A unique collection of 262 toxic substances for high throughput screening (HTS) and high content screening (HCS);
L4150	Featured Novel Bioactive Compound Library	989 compounds
	It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consis...
L4900	Cardiotoxicity Compound Library	131 compounds
	A unique collection of 131 cardiotoxicity inducing compounds for toxicological study;
L7110	Anti-Hypertension Compound Library	678 compounds
	678 hypertension-related small molecules for high-throughput and high-content screening.
L7200	Calcium Channel Compound Library	140 compounds
	A unique collection of 140 calcium channel blockers and agonists for high throughput and high content screening;
L7900	Osteogenesis Compound Library	317 compounds
	A unique collection of 317 osteogenesis related compounds for high throughput and high content screening;
L7500	Coagulation and Anticoagulation Compound Library	144 compounds
	A unique collection of 144 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS);
L9830	Anti-Parkinson's Disease Compound Library	857 compounds
	A unique collection of 857 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS.
L2630	Neuronal Differentiation Compound Library	672 compounds
	672 compounds related to neuronal differentiation, suitable for the drug development of nervous system disease.
L2196	Anti-Ovarian Cancer Compound Library	1867 compounds
	A unique collection of 1867 compounds with anti-ovarian cancer therapeutic activity, can be used for anti-ovarian cancer drug discovery and pharmacological study;
L2194	Anti-Colorectal Cancer Compound Library	1545 compounds
	1545 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening.
L2195	Anti-Prostate Cancer Compound Library	2070 compounds
	2070 compounds associated with prostate cancer that can be used for high-throughput and high-content screening.
L9810	Anti-Fibrosis Compound Library	1180 compounds
	A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS;
L1200	Epigenetics Compound Library	953 compounds
	Well-chosen 953 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L9850	Orally Active Compound Library	2427 compounds
	A unique collection of 2427 of orally active compounds for high-throughput screening and high-content screening.
L3900	DNA Damage & Repair Compound Library	910 compounds
	A unique collection of 910 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS);
L4000	Bioactive Compound Library	14439 compounds
	A collection of 14439 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;
L6720	Anti-COVID-19 Traditional Chinese Medicine Compound Library	1147 compounds
	A unique collection of 1147 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening；
L5300	Mitochondria-Targeted Compound Library	812 compounds
	A unique collection of 812 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine;
L9200	Drug Repurposing Compound Library	4541 compounds
	A unique collection of 4541 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);
L1720	Nucleotide Compound Library	334 compounds
	A unique collection of 334 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs;
L8100	Cell Cycle Compound Library	677 compounds
	A unique collection of 677 cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS);
L4520	Anti-Bacterial Compound Library	904 compounds
	A unique collection of 904 antibacterial bioactive compounds, a powerful tool for antibacterial drug development;
L2100	Anti-Cancer Compound Library	7234 compounds
	A unique collection of 7234 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L6230	Miao medicine Compound Library	534 compounds
	A unique collection of 534 compounds featuring natural product molecules derived from Miao medicine that can be used for high-throughput and high-content screening.
L6710	Anti-Inflammatory Traditional Chinese Medicine Compound Library	1246 compounds
	A collection of 1246 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study；
L7700	Neural Regeneration Compound Library	524 compounds
	A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening;
L6300	Food as Medicine Compound Library	1290 compounds
	A unique collection of 1290 compounds from food as medicine for high throughput and high content screening;
L9840	Anti-Alzheimer's Disease Compound Library	986 compounds
	A unique collection of 986 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS.
L9300	Macrocyclic Compound Library	210 compounds
	210 macrocyclic compounds of known activity for high-throughput, high-content screening;
L9820	Beta-Lactam Compound Library	97 compounds
	A unique collection of 97 beta-lactam compounds, can be used in HTS and HCS;
L2550	Glutamine Metabolism Compound Library	565 compounds
	A unique collection of 565 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and ...
L2520	Glycometabolism Compound Library	702 compounds
	702 glycometabolism-related comounds, can be used for HTS and HCT;
L2510	Lipid Metabolism Compound Library	492 compounds
	A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).
L2800	Serotonin Receptor-Targeted Compound Library	268 compounds
	A unique collection of 268 compounds targeting serotonin receptors for high throughput screening and high content screening;
L2900	Oxidation-Reduction Compound Library	1264 compounds
	1264 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening.
L2530	Mouse Metabolite Compound Library	218 compounds
	A unique collection of 218 mouse metabolites, which can be used for HTS and HCS;
L3510	Methylation Compound Library	128 compounds
	128 methylation-related compounds that can be used for high-throughput and high-content screening.
L3300	Histamine & Melatonin Receptor-Targeted Compound Library	153 compounds
	A unique collection of 153 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L4100	TGF-beta/Smad Compound Library	184 compounds
	A unique collection of 184 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening;
L3100	Hematopoietic Toxicity Compound Library	101 compounds
	A unique collection of 101 compounds with defined hematopoietic toxicity for high throughput and high content drug screening;
L5510	Drug-induced Liver Injury (DILI) Compound Library	1001 compounds
	A unique collection of 1001 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening；
L4600	Selected Plant-Sourced Compound Library	3048 compounds
	A unique collection of 3048 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS);
L4500	Anti-Fungal Compound Library	252 compounds
	A unique collection of 252 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.
L8200	Anti-Aging Compound Library	3279 compounds
	A unique collection of 3279 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);
L8300	Chromatin Modification Compound Library	250 compounds
	A unique collection of 250 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS);
L9000	Apoptosis Compound Library	1760 compounds
	A unique collection of 1760 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening;
L2560	Metabolism Compound Library	2320 compounds
	A unique collection of 2320 metabolic pathway-related bioactive small molecule compounds for high-throughput, high-content screening.
L6220	Traditional Mongolian Medicine Compound Library	950 compounds
	A collection of 950 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening.
L9600	Peptide Compound Library	791 compounds
	791 peptides can be used in peptide drug development and signaling transduction and mechanism study;
L2610	Neurotransmitter Receptor Compound Library	1513 compounds
	A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening；
L2600	Neuronal Signaling Compound Library	2540 compounds
	A unique collection of 2540 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L8000	Stem Cell Differentiation Compound Library	1197 compounds
	A unique collection of 1197 stem cell differentiation signaling targeted compounds for high throughput and high content screening;
L8720	Pyroptosis Compound Library	1066 compounds
	1066 types of active small molecules associated with pyroptosis for high-throughput and high-content screening.
DF4600	Drug-like natural compound library	522 compounds

L9700	Endoplasmic Reticulum Stress Compound Library	193 compounds
	A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS);
L1580	GPCR Compound Library Plus	338 compounds
	Well-chosen 338 GPCR targeting compounds with unique structures;
L2180	Anti-Cancer Compound Library Plus	1468 compounds
	Well-chosen 1468 anti-tumor compounds with unique structures;
L1500	GPCR Compound Library	1940 compounds
	A unique collection of 1940 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;
L4700	Immunology/Inflammation Compound Library	4720 compounds
	A unique collection of 4720 anti-inflammation compounds effective for high throughput screening and high content screening.
L1700	Anti-Viral Compound Library	1040 compounds
	A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;
L3980	DNA Damage and Repair Compound Library Plus	667 compounds
	Well-chosen 667 compounds with unique structures targeting DNA damage & repair;
L1300	PI3K-AKT-mTOR Compound Library	420 compounds
	A unique collection of 420 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling;
L1510	Nuclear Receptor Compound Library	531 compounds
	A unique collection of 531 nuclear receptor signaling targeted compounds for high throughput and high content screening;
L4020	NO PAINS Compound Library	9384 compounds
	TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 9384 small molecules that are suitable for new drug development, signaling pathway research, drug repurposing and other resea...
L2140	Cancer Cell Differentiation Compound Library	406 compounds
	A unique collection of 406 cancer cell differentiation inducing compounds for high throughput and high content screening;
L1900	Anti-Diabetic Compound Library	683 compounds
	A unique collection of 683 diabetes related compounds;
L2191	Anti-Breast Cancer Compound Library	1939 compounds
	A unique collection of 1939 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study；
L5900	CNS-Penetrant Compound Library	509 compounds
	A unique collection of 509 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS);
L4800	Angiogenesis related Compound Library	1353 compounds
	A unique collection of 1353 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);
L4510	Anti-Parasitic Compound Library	419 compounds
	419 well-chosen unique anti-parasitic small molecules;
L5200	Anti-Metabolism Disease Compound Library	1544 compounds
	A unique collection of 1544 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS);
L6750	PBCRBS Traditional Chinese Medicine Compound Library	580 compounds
	A unique collection of 580 compounds derived from traditional Chinese medicines (TCMs) for promoting blood circulation and removing blood stasis.
L8500	HIF-1 Signaling Pathway Compound Library	1336 compounds
	A unique collection of 1336 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies；
L8400	Hematonosis Compound Library	514 compounds
	A unique collection of 514 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS);
L7100	Anti-Obesity Compound Library	2247 compounds
	A unique collection of 2247 anti-obesity compounds for high throughput and high content screening;
L8110	Reprogramming Compound Library	1813 compounds
	A unique collection of 1813 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening.
L2910	Antioxidant Compound Library	1314 compounds
	Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. ...
L3410	Preclinical Compound Library	701 compounds
	A unique collection of 701 preclinical compounds for high throughput screening (HTS) and high content screening (HCS);
L2501	Human Endogenous Metabolite Compound Library Plus	1283 compounds
	A unique collection of 1283 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening.
L3800	NF-κB Signaling Compound Library	729 compounds
	A unique collection of 729 compounds targeting NF-κB signaling for high throughput screening and high content screening;
L4300	Wnt/Hedgehog/Notch Compound Library	237 compounds
	A unique collection of 237 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening;
L9860	Antidepressant Compound Library	1163 compounds
	1163 compounds associated with depression that can be used for high-throughput and high-content screening
L6740	Anti-Colorectal Cancer Traditional Chinese Medicine Compound Library	382 compounds
	A collection of 382 TCM monomers with anti-colorectal activity. An effective tool for drug development and pharmacological studies.
L2193	Anti-Liver Cancer Compound Library	1787 compounds
	1787 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies.
L2521	Glycolysis Compound Library	555 compounds
	555 glycolysis-related active compounds for high-throughput and high-content screening.
L6210	Tibetan medicine Compound Library	747 compounds
	A collection of 747 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening.
L4710	Nonsteroidal Anti-Inflammatory Compound Library	530 compounds
	530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening.
L4010	Bioactive Compounds Library Max	22555 compounds
	A collection of 22555 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.
L2190	Anti-Lung Cancer Compound Library	1702 compounds
	A unique collection of 1702 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study；
L1520	Membrane Protein-targeted Compound Library	4175 compounds

L3400	Clinical Compound Library	3404 compounds
	A unique collection of 3404 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);
L2170	Immuno-Oncology Compound Library	449 compounds
	A unique collection of 449 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening；